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Abstract: Background: Frailty, a very important complication of increasing age, is a well-recognised 
concept although it has not been accurately measured in the clinical setting. The aim of this literature 
review is to summarise commonly used frailty screening tools, and to describe how new 
measurement methods have been developed recently. Methods: Several frailty measurement tools 
including the most cited and newly developed scales have been described in this review. We 
searched the MEDLINE using the search terms; “frailty score, scale, tool, instrument, index, 
phenotype” and then summarised selected tools for physical, cognitive, emotional and co-morbidity 
domains. Results: The most cited frailty measurement methods developed from 1999 to 2005 are 
primarily criteria for physical frailty (e.g., frailty phenotype). More recently developed tools (e.g., 
triad of impairment and multidimensional frailty score) consider cognitive and emotional domains 
in addition to physical deficit in measuring frailty. Co-morbidity has also been considered as a 
domain of frailty in several measurement tools. Conclusion: Although frailty tools have traditionally 
assessed physical capability, cognitive and emotional impairment often co-exist in older adults and 
may have shared origins. Therefore, newer tools which provide a composite measure of frailty may 
be more relevant for future use.  
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1. Background 
Population ageing is a major concern in the 21st century with significant health and 
socioeconomic consequences. It is estimated there will be more than two billion people globally aged 
60 years or over by 2050 [1]. Cumulative decline in many physiological systems and the increased 
risk of vulnerability resulting from the ageing process is conceptualised as frailty. Frailty is described 
as one of the most challenging expressions of ageing that decreases the quality of life and 
independence of older adults [2]. Older frail people also experience dramatic decline in physical and 
mental functions and have poorer outcomes after even apparently minor stressors such as mild 
physical disorders and anxiety [3]. Although frailty is a long-established and well-recognised clinical 
syndrome, there is no consistent way of measuring it in the clinical setting [4]. A model of frailty that 
could precisely measure and therefore predict this syndrome to potentially prevent, delay its 
progress, or reverse it at early stages is of great importance in the older adults’ health [5]. 
It is also recognised that frailty should be seen as a multidimensional syndrome [6] affecting the 
physical and mental function of the elderly. Cognitive [7–9] and emotional impairment [10] resulting 
from ageing had been frequently reported in the frail older people while, many of the screening tools 
determine only physical deficits as a proxy measures of frailty [5]. Considering the concurrence of 
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mental and physical dysfunction in the elderly, it seems that there is a necessity of including mental 
impairment in addition to physical impairment in measuring frailty [11]. 
Co-existence of multiple chronic conditions or co-morbidity is common in older people. Co-
morbidity could negatively affect the physical and mental function of older adults; however, it should 
be distinguished from the frailty concept due to different prognoses, outcome and treatment 
strategies [12]. 
The purpose of this literature review is to summarise the most used frailty measurement 
methods along with recently developed frailty tools, which incorporate mental function in addition 
to physical frailty. We selected the six best-known tools based on the recent systematic review by 
Buta et al. [13]. Frailty tools had been mapped onto to physical, cognitive, emotional and co-morbidity 
domains. 
2. Ageing and Frailty 
Ageing is associated with a gradual decline in physical functioning. However, the rate of decline 
varies and hence ageing is not necessarily coupled with frailty [14]. The concept of frailty underpins 
the need to better understand the variance in individuals with the same chronological age in their 
function, resilience and adverse outcome [15]. Many protective and risk factors may influence frailty 
during the life course. Many of these factors have complex interactions among one another as well as 
independent effects on frailty. Therefore, it is important to understand the onset and progression of 
frailty in older people in order to develop methods for early detection and prevention. Early life, mid-
life and late life predictors and risk factors (e.g., genetic, epigenetic, psychological, socio-economic, 
lifestyle characteristics, nutritional status, multi-morbidity and medications) should be considered to 
explain the diversity in population ageing more accurately [5,14]. 
It is also important to consider the difference between men and women in frailty status in late 
life. A systematic review reported that at any given age women have a higher Frailty Index score, 
although, they tolerate the adverse health outcome of frailty better and live longer than men [16]. 
There are many possible explanations for this phenomenon including differences in inflammatory 
markers [17], hormones, disease patterns and behavioral heterogeneity [18] in men and women. 
Studies also suggested that the higher prevalence of frailty in women might be due to psychological 
symptoms and lower cognitive functioning [18,19]. 
3. Frailty as Physical Impairment 
Frailty phenotype is the most well-known frailty assessment developed by Fried et al. in 2001 
[20]. This model defines frailty as the existence of three or more of the following five components of 
physical impairment in older adults: shrinkage (weight loss), exhaustion, weaknesses, low gait speed and 
low physical activity. Similarly, impaired physical function has been identified as a surrogate marker 
of frailty in the Vulnerable Elders Survey (VES-13) [21] and physical frailty measurement tools 
developed by Gill et al. [22] (Table 1). 
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Table 1. Most cited frailty measurement tools. 
Tools/Study Authors Physical Domain/Tests 
Emotional 
Domain/Tests 
Cognitive 
Domain/Tests 
Co-Morbidity 
Frailty phenotype/Cardiovascular 
Health Study 
Fried et al. 2001 [20] 
- Unintentional weight loss 
(shrinkage)  
- Self-reported exhaustion  
- Weakness (grip strength)  
- Slow walking speed  
- Low physical activity  
No No No  
Frailty Index  
(FI; accumulation of deficit)/Canadian 
Study of Heath and Aging  
Rockwood et al. 1999 
[23] 
- Walk with help  
- Needing assistance with Activity of 
Daily Living (ADL) 
No 
Cognitive 
impairment 
- Bladder or bowel incontinence  
- Diagnosis of dementia 
Mitnitski et al. 2001 
[24] 
92 deficits presentation as yes and no 
including:  
- Abnormal laboratory values  
- Disabilities 
- Difficulty with 
mood  
- Feeling sad or 
depressed etc. 
Difficulty with 
memory etc. 
- Diabetes  
- Stroke etc. 
Mitnitski et al. 2002 
[25] 
20 deficits presentation as yes and no 
including:  
- Impaired mobility  
- Gait abnormality  
- Impaired vibration sense  
- Difficulty in toileting, cooking, 
bathing, going out, grooming, 
dressing  
- Changes in sleep  
- Limb tone abnormality 
No No 
- Vision loss  
- Hearing loss  
- Vascular problems  
- Resting tremor  
- Diabetes  
- Hypertension  
- Urinary complaints  
- Skin problems  
- Gastro-intestinal problem 
Clinical Frailty Scale continue of the 
FI/Canadian Study of Heath and Aging 
Rockwood et al. 2005 
[26] 
70 deficits presentation as yes and no 
including:  
- Abnormal laboratory values  
- Disabilities  
- Falls 
- Mood problems 
- Feeling sad, 
blue, depressed  
- History of 
depressed mood 
- Memory changes 
- Short-term 
memory 
impairment  
- Long-term 
memory 
impairment 
- Cardiac problems  
- Myocardial infarction  
- Arrhythmia  
- Congestive heart failure 
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The Vulnerable Elders Survey (VES-13) Saliba et al. 2001 [21] 
- Age  
- Self-rated health  
- Self-reported physical function 
limitation in walking, bending, 
reaching etc. 
- Needing assistance with Activity of 
Daily Living/Instrumental Activity of 
Daily Living  
No No No 
Physical frailty/Randomised controlled 
trail 
Gill et al. 2002 [22] 
- Rapid gait test (walking back and 
forth over a 10-foot (3-m) course as 
quickly as possible)  
- Single chair stand 
No No No 
Frail scale/Health in Men Study 
Abellan van kan et 
al. 2008, Hyde et al. 
2010 [27,28] 
- Fatigue (SF-36)  
- Resistance—ability to climb a single 
flight of stairs (SF-36)  
- Ambulation—ability to walk one 
block (SF-36)  
- Loss of weight—more than 5% 
(between 4 to 5 years) 
No No 
- Illnesses more than 5 in list of 14 diseases 
including: arthritis, diabetes, dementia, angina 
or myocardial infarction, hypertension, stroke, 
asthma 
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These measurement methods consist of a subjective measure of physical activity (self-reported 
items) as well as directly quantified variables, such as single chair stand test. Loss of mass, strength 
and function of muscles or sarcopenia is a key component of frailty in the physical impairment 
models of frailty [20]. Gait speed is another reliable key component of physical frailty models [22]. 
Some degree of physical dysfunction is an inevitable consequence of ageing and manifests as a 
key feature in many frail older adults. Therefore, these frailty tools successfully recognize the physical 
dimension of frailty, while they fail to consider the impact of cognitive and emotional function in 
development and progression of frailty and its impact on outcomes such as quality of life and 
independent living. The manifestations of an ageing brain including cognitive and emotional 
impairment could influence the physical function of older adults. It is well recognised that an 
impaired mood is associated with reduced physical activity, increase in sarcopenia and therefore 
increases the prevalence of frailty [29]. There is also growing evidence of a strong association between 
cognitive decline and physical frailty with shared subcellular pathophysiology that increase the 
vulnerability that causes a poorer outcome in older adults [9,11,30].  
4. Frailty as a Co-Morbidity Index 
The Frailty Index (FI) and clinical frailty scale developed by Rockwood and Mitnitski from 1999 
to 2005 [23–26] count deficits in health to create a frailty measurement tool. Items include the presence 
and severity of current diseases, ability in activities of daily living, and physical and neurological 
signs from the clinical examinations [26]. The FRAIL scale, developed by Abellan van Kan et al. also 
considers the accumulation of deficits as a substitute measure of frailty. Using this scale, a deficit is 
recorded for illness if the participant reported more than five from a list of 14 different chronic 
diseases [27,28] (Table 1). 
The relationship between chronic conditions and frailty is complex because they share common 
risk factors and biological pathways [31]. Multiple chronic diseases (or multi-morbidity) are 
prevalent in frail older people and can significantly decrease the quality of life [14]. Indeed, frailty is 
an unavoidable outcome of the advanced stage of some chronic disorders such as arthritis, congestive 
heart failure and diabetes [31]. Nevertheless, they do not necessarily co-exist; distinguishing between 
them has important clinical implications because they confer different prognoses, thus specific 
interventions are required [12]. 
5. Frailty, Cognitive and Emotional Impairment 
A comprehensive frailty tool could potentially enable us to better predict adverse outcome and 
provide a therapeutic target for intervention in the elderly. The requirement to include cognitive and 
psychological factors in identification, assessment and management of frailty has been increasingly 
recognised [32,33].  
A study by Rothman et al. provided strong evidence to support the use of cognitive impairment 
as an independent criterion of frailty. They investigated the prognostic effect of seven potential frailty 
criteria, including five from the Fried phenotype in addition to cognitive impairment and depressive 
symptoms. The results of this study showed that cognitive impairment was independently associated 
with chronic disability, long-term nursing home stay, and death [34]. Similarly, a prospective cohort 
study in patients with a coronary artery disease included cognitive and emotional impairment as a 
criterion of frailty in addition to physical impairment. This frailty index accurately predicted 
increased disability and meaningful decline in health-related quality of life at 12 months in this study 
population [35]. 
Ageing is associated with the structural and physiological changes in the brain that could affect 
cognitive and physical function of older adults. Buchman et al. [9] proposed common pathological 
pathways such as macro infarcts, and Nigral neuronal loss may explain the correlation between 
cognitive decline and physical frailty. In an earlier study, they also reported that increase in physical 
frailty is associated with brain pathologies of Alzheimer diseases (AD) and concluded that physical 
frailty is a non-cognitive manifestation of AD pathology that precedes the onset of dementia [7].  
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A recent cohort study by Murray et al. showed that hyperintensities in the deep brain structure 
are linked to depressive symptoms and that this association is mediated via impairment in cognitive 
and physical function [36]. Furthermore, chronic inflammation that is associated with poor physical 
function and frailty also plays an important role in vascular cognitive impairment [37]. Recent studies 
have shown that depression is significantly associated with frailty in older adults and that the two 
syndromes have common pathophysiological mechanisms such as hormonal changes and 
inflammation [29].  
6. Frailty as Multidimensional Impairment  
Recent studied have considered the multidimensional nature of frailty by including cognitive 
and emotional impairment as critical domains.  
Kennedy et al. used a questionnaire to create a frailty index using the Canadian Multicentre 
Osteoporosis Study (CaMos) dataset. The CaMos Frailty Index (CaMos FI) is based on the cumulative 
deficit model and includes cognition and emotional function in assessing frailty [38]. CaMos FI 
quantifies the incidence of fractures over 10 years according to a degree of frailty in men and women 
aged 25 years and older. However, there is a concern regarding the validity of the responses from 
cognitively impaired participants (Table 2). 
Table 2. Recently developed frailty measurement tools. 
Tools/Study Authors Physical 
Domain/Tests 
Emotional 
Domain/Tests 
Cognitive 
Domain/Tests 
Co-Morbidity 
CaMos Frailty 
index/Canadian 
Multicentre 
Osteoporosis Study 
Kennedy 
et al. 2014 
[38] 
30 deficit items 
including:  
- Walking  
- General health  
- Limitation in 
lifting/carrying 
groceries etc. 
- Interference with 
social activities due 
to physical/emotional 
health (last 4 weeks) 
- Cognition in six 
levels:  
able to remember 
most things, think 
clearly and solve day 
to day problems = 0 to 
unable to remember 
anything at all and 
unable to think or 
solve day to day 
problems = 1 
- Osteoarthritis  
- Breast cancer  
- Hypertension etc.. 
Multidimensional 
Frailty Score (MFS) 
Choi et al. 
2015 [39] 
- Serum albumin 
- Mid-arm 
circumference  
- Activity of Daily 
Living (modified 
Barthel Index)  
- Instrumental 
Activity of Daily 
Living (Lawton 
and Brody Index) 
- Nutritional 
status (Mini 
Nutritional 
Assessment)  
- Depression (short 
form of the Korea 
Geriatric Depression 
Scale) 
- Dementia (Korean 
version of the Mini-
Mental State 
Examination)  
- Delirium(Nursing 
Delirium Screening 
Scale) 
- Charlson 
Comorbidity Index 
- Malignant disease 
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Care Partner-
derived Frailty 
Index based upon 
Comprehensive 
Geriatric 
Assessment (CP-FI-
CGA) 
Goldstein 
et al. 2015 
[40] 
Yes or no answer 
to the following 
questions:  
- Falls  
- Sleep problems 
- Exhaustion  
- Speech 
problems  
- Loss of appetite 
- Balance 
problems  
- Dizzy or 
lightheaded  
- Assistance with 
walking (aid, 
stand by)  
- Hold onto 
furniture to 
prevent falls  
- Difficulties in 
getting out of bed 
or chair,walking, 
managing 
medications…  
- Unable to Drive 
- Weight Loss 
(more than 10 
pounds in six 
months)  
- Weakness 
- Depression Yes = 1, 
Low Mood = 0.5, No 
= 0  
- Anxiety  
- Health attitude 
Excellent = 0, Good = 
0.25, Fair = 0.5, Poor = 
1.0 
-Memory Problems 
- Hypertension  
- Stroke  
- Diabetes  
Arthritis  
Parkinson’s 
Disease,  
recent broken 
bones,  
Problems including: 
Heart, Teeth, Lungs 
or breathing, 
stomach, kidneys, 
feet, skin, thyroid, 
hearing, eyesight, 
bowel, bladder  
Triad of 
impairment 
(TOI)/Aberdeen 
Birth Cohort 
Murray et 
al. 2016 
[36] 
- Subjective 
measure of 
physical health 
(SF-36) including: 
Physical 
Functioning, 
Role-Physical 
Bodily Pain and 
General Health  
- Walks time (the 
time in seconds 
for walking 6 
meters 
normalised for 
height) 
- Self-reported 
Hospital Anxiety and 
Depression Scale 
(HADS-A-D)  
- Subjective measure 
of emotional health 
(SF-36) including: 
Vitality, social 
functioning, role-
emotional and mental 
health  
Memory tests 
including:  
- Non-verbal 
reasoning (Raven’s 
Standardised 
Progressive Matrices)  
- Spatial ability (Block 
Design Test)  
- Mental speed (Digit 
Symbol Test)  
- Verbal memory 
(Rey’s Auditory 
Verbal Learning Test) 
No 
Frailty Index 
(FI)/Rotterdam 
study 
Schoufour 
et al. 2016 
[41] 
- BMI  
- Biomarkers  
- Falling  
- Joint complaints 
- Mobility  
- Stanford Health 
Assessment 
Questionnaire for 
physical activity 
Activities of Daily 
Living (Lawton 
Index)  
- Hospital 
admission 
- Self-reported Centre 
for Epidemiologic 
Studies Depression 
Scale to measure 
(CES-D):  
- Depressed affect  
- Positive affect  
- Interpersonal  
- Somatic and 
retarded activity 
- Forgetfulness  
- Mini Mental State 
Examination  
- Word Fluency test  
- Stroop test  
- Aphasia  
- Letter-Digit 
Substitution Test: the 
number of correct 
digits 
- Hyperlipidaemia  
- HDL  
- Systolic blood 
pressure  
- Cancer  
- COPD/Asthma  
- Cardiovascular 
diseases  
- Stroke  
- Diabetes Mellitus 
- Age-related 
macular 
degeneration 
The Multidimensional Frailty Scores (MFS) [39] and the Care Partner- Derived Frailty Index (CP-
FI-CGA) [40] were developed based on the comprehensive geriatric assessment (CGA). CGA is a gold 
standard for management of frail older people, involving a holistic, multidimensional, 
interdisciplinary assessment of an individual and is associated with improved outcomes in the 
elderly [42]. Mental impairment, including memory and mood, and chronic conditions are 
considered as domains of frailty in the CGA based measurement tools (Table 2). 
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For measuring MFS physical, cognitive and emotional functions are evaluated by the activity of 
daily living (ADLs) and instrumental ADLs (IADLs), the Korean version of the Mini-Mental State 
Examination and the Korean Geriatric Depression Scale respectively. MFS also assesses nutritional 
status, the risk of delirium, co-morbidity and malignant diseases, serum albumin and mid-arm 
circumferences as well as other domains of frailty. This frailty indicator can independently predict 
postoperative complications and prolonged hospital stay, however the sample included women only 
and therefore this study might not be generalizable in the community setting [39]. In addition, CGA 
based frailty indices have been criticized as cumbersome because they need a trained geriatric team 
and are time consuming in the clinical setting [42].  
CP-FI-CGA has been developed to improve the feasibility of the CGA utilization in developing 
a frailty index. It is based on a questionnaire including 44 deficit items that are completed by the care 
partner and applied to predict the survival in 200 patients admitted to the emergency medical 
services and geriatric ambulatory care. The contribution of carers is notable particularly in the 
presence of cognitive impairment. Similar to other deficit models, CP-FI-CGA includes chronic 
conditions as components of frailty [40]. 
The co-occurrence of physical, cognitive and emotional decline had been collectively named 
triad of impairment (TOI) and used as a surrogate marker of frailty in the Cardiovascular Health 
study [43] and Aberdeen Birth Cohort (ABC) study [36,44]. TOI proposed in the ABC study included 
both subjective (self-reported; SF-36, HADS depression and anxiety questionnaire) and objective 
(memory tests, gait speed test) measures of function quantifying as a continuing variable to represent 
frailty status. Using a graded measurement tool will enable a clinician to both identify and grade 
frailty for severity [2]. This frailty score had been developed in a relatively healthy sample of men 
and women aged around 64 years and 68 years, it is easy to measure and therefore it is applicable in 
the clinical setting for general population. Early-life cognitive ability is a strong predictor of TOI in 
late life and occupational profile, polypharmacy and personality traits such as neuroticism have been 
shown to be associated with it. This study has revealed the importance of considering a life-course 
approach to predict and potentially reduce frailty in older adults. However, the validity of TOI and 
whether it could predict adverse health outcomes such as hospitalization and mortality rate in late 
life need to be estimated in other studies [44]. 
In the Rotterdam study, a frailty index had been created based on the accumulation of a deficit 
model and forty-five different deficits related to mood, cognition, nutritional status, biomarkers, 
functional status and diseases and conditions have been assessed. The criterion validity of it had been 
evaluated by investigating the association between the frailty index and survival. Although the 
Rotterdam FI considers different dimensions of frailty, including cognitive and emotional function, 
it is time consuming and contains many expensive measurements (such as biomarkers) making it less 
practical in the clinical setting [41].  
7. Summary 
In this narrative review, we have summarised the most-cited and recently developed frailty tools 
that include physical, cognitive, emotional and co-morbidity domains and discussed the advantages 
and drawbacks briefly. The challenge in developing a comprehensive, easily applicable tool to 
quantify frailty is still ongoing and will always be a compromise between ease of use and complexity 
of domains assessed. There is increasing recognition of mental frailty as component of frailty tools 
and this approach has become more common. It is important to recognise that frailty is a spectrum 
and distinction as frail or not-frail is simplistic, particularly in the context of individual variation in 
social vulnerability. Analysis of the independent impact of frailty on outcome may help to better 
understand the effectiveness of frailty prevention or management strategies. 
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